Valproic Acid

Valproic Acid

SCHEMBL2372220

C=CC(N)CCC(=O)O.CCCC(CCC)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ALDH5A1

The experimentally established mechanism targets of Valproic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.70
SLC6A2 P23975 1/20 0.70
SLC6A4 P31645 1/20 0.70
BLM P54132 1/20 0.70
MEN1 O00255 1/20 0.70
CYP2D6 P10635 1/20 0.70
TSHR P16473 1/20 0.70
NFKB1 P19838 1/20 0.70
CYP2C19 P33261 1/20 0.70
KMT2A Q03164 1/20 0.70
CHRM1 P11229 1/20 0.53
AKR1A1 P14550 1/20 0.53
CHRM3 P20309 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2C P28335 1/20 0.53
ADRA1A P35348 1/20 0.53
HRH1 P35367 1/20 0.53
DRD3 P35462 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valproic Acid SCHEMBL1004170 0.94 SLC6A3 (0.62) SLC6A3SLC6A2SLC6A4BLMMEN1
Vigabatrin SCHEMBL465981 0.84
Vigabatrin SCHEMBL5785801 0.84 CYP2D6 (1.00) SLC6A3SLC6A2SLC6A4BLMMEN1
Vigabatrin SCHEMBL9132153 0.84
Vigabatrin SCHEMBL26714 0.84
Vigabatrin SCHEMBL31159534 0.84
Vigabatrin SCHEMBL20659806 0.82 CYP2D6 (0.95) SLC6A3SLC6A2SLC6A4BLMMEN1
SCHEMBL2230782 0.80 CHRM1 (0.76) SLC6A3CHRM1AKR1A1CHRM3HTR2A
Valproic Acid SCHEMBL6884475 0.79 SLC1A2 (0.69) SLC6A3BLMKMT2ACHRM1AKR1A1
SCHEMBL30860117 0.78 CHRM1 (0.67) SLC6A3CHRM1AKR1A1CHRM3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011113904-A1 MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-09-22 WO claimed
WO-2011113904-A1 MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-09-22 WO disclosed